Phrenilin with Caffeine and Codeine 50 mg / 30 mg / 325 mg / 40 mg Oral Capsule
RxNorm 993950
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 993950 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Phrenilin with Caffeine and Codeine 50 mg / 30 mg / 325 mg / 40 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Acetaminophen 325 mg / butalbital 50 mg / caffeine 40 mg / codeine phosphate 30 mg Oral Capsule [Phrenilin with Caffeine and Codeine]
(Atom ID: 12366476)
SY
Synonym (SY):
APAP 325 mg / butalbital 50 mg / Caffeine 40 mg / Codeine Phosphate 30 mg Oral Capsule [Phrenilin with Caffeine and Codeine]
(Atom ID: 3857893)
SY
Synonym (SY):
Phrenilin with Caffeine and Codeine (acetaminophen 325 mg / butalbital 50 mg / caffeine 40 mg / codeine phosphate 30 mg) Oral Capsule
(Atom ID: 3267222)
SY
Synonym (SY):
Phrenilin with Caffeine and Codeine (APAP 325 mg / butalbital 50 mg / caffeine 40 mg / codeine phosphate 30 mg) Oral Capsule
(Atom ID: 3267227)
PSN